000 01239 a2200349 4500
005 20250515025941.0
264 0 _c20071026
008 200710s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656566.7.8.1005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrebs, Michael
245 0 0 _aCurrent schizophrenia drugs: efficacy and side effects.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cJun 2006
300 _a1005-16 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBasal Ganglia Diseases
_xetiology
650 0 4 _aCognition
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLong QT Syndrome
_xetiology
650 0 4 _aPatient Compliance
650 0 4 _aQuality of Life
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSecondary Prevention
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aLeopold, Karolina
700 1 _aHinzpeter, Axel
700 1 _aSchaefer, Martin
773 0 _tExpert opinion on pharmacotherapy
_gvol. 7
_gno. 8
_gp. 1005-16
856 4 0 _uhttps://doi.org/10.1517/14656566.7.8.1005
_zAvailable from publisher's website
999 _c16320442
_d16320442